The announcement details that Zhejiang Yilikan Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for its application to list a chemical raw material drug. The drug, named "Aminophylline," is intended for production and marketing. The approval is expected to enhance the company's core competitiveness in the market.
Summary generated by AI · Always verify with source document
Recently, Zhejiang Yilikan Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") received a notification from the National Medical Products Administration (hereinafter referred to as "the Administration") regarding the approval of its application for the listing of the chemical raw material drug. The relevant situation is as follows:
| Chemical Raw Material Name | Registration Number |
|---|---|
| Aminophylline | Y20240001559 |
| Y20250000016 |
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.